Immunocore Holdings plc
IMCR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2 | $2 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $2 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 5.8% | 4.3% | 11.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 99.5% | 98.9% | 99.1% | 99.6% |
| EBITDA | $0 | -$0 | $0 | -$0 |
| % Margin | 4% | -6.5% | 10.6% | -18.2% |
| Net Income | $0 | -$0 | $0 | -$0 |
| % Margin | 0.8% | -10.5% | 5.4% | -28.3% |
| EPS Diluted | 0.016 | -0.21 | 0.097 | -0.47 |
| % Growth | 107.4% | -316.3% | 120.7% | – |
| Operating Cash Flow | -$0 | $0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | $0 | -$0 |